OrganOx, a British developer of technologies to maintain organs for transplant, raised $142m in primary and secondary funding ...

OrganOx's metra normothermic machine perfusion platform gained approval in Australia, Europe, Canada, and the US.

OrganOx, with its system for actively preserving viable donor tissue ahead of a transplant procedure, has raised $142 million ...

Organox Ltd. raised $142 million in financing to accelerate the growth of its Metra platform that preserves and transport livers for transplantation. The funds will allow the company to strengthen its ...

OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth opportunities.

OXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, successfully completed a $142 million primary and secondary ...

Nov. 12, 2024 (GLOBE NEWSWIRE) -- OrganOx Ltd., a medical technology company developing innovative solutions for organ preservation, and eGenesis, Inc., a biotechnology company developing ...

OXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, successfully completed a $142 million primary and secondary equity ...

Financing strengthens OrganOx to expand its leadership position in organ technologyOXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025., a leading organ medical technology company, successfully co ...